Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Bardia, Aditya
Item TypeName
Concept Cyclin D1
Concept Cyclin-Dependent Kinase 6
Concept Cyclin-Dependent Kinase 4
Concept Cyclin-Dependent Kinases
Academic Article Targeting the cyclin D-cyclin-dependent kinase (CDK) 4/6-retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current status, and future directions.
Academic Article Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors.
Academic Article Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.
Academic Article Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer.
Academic Article Mechanism of Action and Clinical Impact of Ribociclib-Response.
Academic Article Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer.
Academic Article Predictors of systemic therapy sequences following a CDK 4/6 inhibitor-based regimen in post-menopausal women with hormone receptor positive, HEGFR-2 negative metastatic breast cancer.
Academic Article CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.
Academic Article Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.
Academic Article Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer.
Academic Article Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
Academic Article Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.
Search Criteria
  • Cyclin E
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.